Bonus Issues

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE262.95-4.35 (-1.63 %)
PREV CLOSE ( ) 267.30
OPEN PRICE ( ) 262.85
BID PRICE (QTY) 262.85 (211)
OFFER PRICE (QTY) 263.20 (499)
VOLUME 305323
TODAY'S LOW / HIGH ( )260.00 265.50
52 WK LOW / HIGH ( )217.5 307
NSE262.75-4.45 (-1.67 %)
PREV CLOSE( ) 267.20
OPEN PRICE ( ) 265.00
BID PRICE (QTY) 262.70 (50)
OFFER PRICE (QTY) 262.75 (769)
VOLUME 4712410
TODAY'S LOW / HIGH( ) 259.85 265.35
52 WK LOW / HIGH ( )217.5 307.1

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.